The psychedelic start-up Mindstate Design Labs, announced the company received approval from the U.S. Food and Drug Administration and the European Medicine Agency to begin human clinical trials studying the compound 5-MeO-MiPT.
Psychonauts call 5-MeO-MiPT “moxy.” Mindstate chose to develop the substance because 5-MeO-MiPT is “a psychedelic tofu,” according to DiNardo: Just as tofu takes on the flavors of any dish it’s put in, the drug takes on the properties of the other drugs with which it’s administered.
Quisque iaculis facilisis lacinia. Mauris euismod pellentesque tellus sit amet mollis.